These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

52 related items for PubMed ID: 21537834

  • 1. Endothelin-1 does not impair insulin-induced angiogenesis in vitro.
    Pellegatta F, Brambilla C, Reduzzi A, Bragheri M, Zerbini G, Catapano AL.
    Int J Mol Med; 2011 Sep; 28(3):443-8. PubMed ID: 21537834
    [Abstract] [Full Text] [Related]

  • 2. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
    Lovren F, Pan Y, Shukla PC, Quan A, Teoh H, Szmitko PE, Peterson MD, Gupta M, Al-Omran M, Verma S.
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
    [Abstract] [Full Text] [Related]

  • 3. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.
    Tamura K, Hashimoto K, Suzuki K, Yoshie M, Kutsukake M, Sakurai T.
    Eur J Pharmacol; 2009 May 21; 610(1-3):61-7. PubMed ID: 19374835
    [Abstract] [Full Text] [Related]

  • 4. Effects of hesperidin on cyclic strain-induced endothelin-1 release in human umbilical vein endothelial cells.
    Chiou CS, Lin JW, Kao PF, Liu JC, Cheng TH, Chan P.
    Clin Exp Pharmacol Physiol; 2008 Aug 21; 35(8):938-43. PubMed ID: 18430059
    [Abstract] [Full Text] [Related]

  • 5. Antiangiogenic activity of beta-eudesmol in vitro and in vivo.
    Tsuneki H, Ma EL, Kobayashi S, Sekizaki N, Maekawa K, Sasaoka T, Wang MW, Kimura I.
    Eur J Pharmacol; 2005 Apr 11; 512(2-3):105-15. PubMed ID: 15840394
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects.
    Maffucci T, Piccolo E, Cumashi A, Iezzi M, Riley AM, Saiardi A, Godage HY, Rossi C, Broggini M, Iacobelli S, Potter BV, Innocenti P, Falasca M.
    Cancer Res; 2005 Sep 15; 65(18):8339-49. PubMed ID: 16166311
    [Abstract] [Full Text] [Related]

  • 7. Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis.
    Hung SC, Pochampally RR, Chen SC, Hsu SC, Prockop DJ.
    Stem Cells; 2007 Sep 15; 25(9):2363-70. PubMed ID: 17540857
    [Abstract] [Full Text] [Related]

  • 8. Vascular endothelial growth factor-B promotes in vivo angiogenesis.
    Silvestre JS, Tamarat R, Ebrahimian TG, Le-Roux A, Clergue M, Emmanuel F, Duriez M, Schwartz B, Branellec D, Lévy BI.
    Circ Res; 2003 Jul 25; 93(2):114-23. PubMed ID: 12805240
    [Abstract] [Full Text] [Related]

  • 9. Stimulatory effects of low-dose 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activated protein kinase.
    Uruno A, Sugawara A, Kudo M, Satoh F, Saito A, Ito S.
    Hypertens Res; 2008 Nov 25; 31(11):2085-96. PubMed ID: 19098381
    [Abstract] [Full Text] [Related]

  • 10. Parallel signaling pathways in endothelin-1-induced proliferation of U373MG astrocytoma cells.
    He S, Dibas A, Yorio T, Prasanna G.
    Exp Biol Med (Maywood); 2007 Mar 25; 232(3):370-84. PubMed ID: 17327470
    [Abstract] [Full Text] [Related]

  • 11. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells.
    Dai J, Peng L, Fan K, Wang H, Wei R, Ji G, Cai J, Lu B, Li B, Zhang D, Kang Y, Tan M, Qian W, Guo Y.
    Oncogene; 2009 Sep 24; 28(38):3412-22. PubMed ID: 19597469
    [Abstract] [Full Text] [Related]

  • 12. Ruboxistaurin, a PKCbeta inhibitor, inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt.
    Nakamura S, Chikaraishi Y, Tsuruma K, Shimazawa M, Hara H.
    Exp Eye Res; 2010 Jan 24; 90(1):137-45. PubMed ID: 19825373
    [Abstract] [Full Text] [Related]

  • 13. Novel function of ascorbic acid as an angiostatic factor.
    Ashino H, Shimamura M, Nakajima H, Dombou M, Kawanaka S, Oikawa T, Iwaguchi T, Kawashima S.
    Angiogenesis; 2003 Jan 24; 6(4):259-69. PubMed ID: 15166494
    [Abstract] [Full Text] [Related]

  • 14. Neuromedin B induces angiogenesis via activation of ERK and Akt in endothelial cells.
    Park HJ, Kim SR, Bae SK, Choi YK, Bae YH, Kim EC, Kim WJ, Jang HO, Yun I, Kim YM, Bae MK.
    Exp Cell Res; 2009 Nov 15; 315(19):3359-69. PubMed ID: 19703440
    [Abstract] [Full Text] [Related]

  • 15. Hypoxia-induced mitogenic factor enhances angiogenesis by promoting proliferation and migration of endothelial cells.
    Tong Q, Zheng L, Li B, Wang D, Huang C, Matuschak GM, Li D.
    Exp Cell Res; 2006 Nov 01; 312(18):3559-69. PubMed ID: 16982054
    [Abstract] [Full Text] [Related]

  • 16. Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function.
    McGonigle JS, Giachelli CM, Scatena M.
    Angiogenesis; 2009 Nov 01; 12(1):35-46. PubMed ID: 19105036
    [Abstract] [Full Text] [Related]

  • 17. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis.
    Naumova E, Ubezio P, Garofalo A, Borsotti P, Cassis L, Riccardi E, Scanziani E, Eccles SA, Bani MR, Giavazzi R.
    Clin Cancer Res; 2006 Mar 15; 12(6):1839-49. PubMed ID: 16551869
    [Abstract] [Full Text] [Related]

  • 18. In vitro angiogenic effects of pancreatic bile salt-dependent lipase.
    Rebaï O, Le Petit-Thevenin J, Bruneau N, Lombardo D, Vérine A.
    Arterioscler Thromb Vasc Biol; 2005 Feb 15; 25(2):359-64. PubMed ID: 15569825
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.
    Mannell H, Hellwig N, Gloe T, Plank C, Sohn HY, Groesser L, Walzog B, Pohl U, Krotz F.
    J Vasc Res; 2008 Feb 15; 45(2):153-63. PubMed ID: 17962719
    [Abstract] [Full Text] [Related]

  • 20. The HUVEC/Matrigel assay: an in vivo assay of human angiogenesis suitable for drug validation.
    Skovseth DK, Küchler AM, Haraldsen G.
    Methods Mol Biol; 2007 Feb 15; 360():253-68. PubMed ID: 17172733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.